Qualigen Therapeutics Inc (QLGN) is up Wednesday morning, with the stock climbing 4.46% in pre-market trading to 3.51.
QLGN's short-term technical score of 14 indicates that the stock has traded less bullishly over the last month than 86% of stocks on the market. In the Biotechnology industry, which ranks 96 out of 146 industries, QLGN ranks higher than 22% of stocks.
Qualigen Therapeutics Inc has risen 0.90% over the past month, closing at $3.33 on December 23. During this period of time, the stock fell as low as $3.01 and as high as $3.77. The company has an average price target of $10.00.
Qualigen Therapeutics Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 89 by this metric, QLGN ranks better than 6% of stocks.
Important Dates for Investors in QLGN:
-Qualigen Therapeutics Inc is set to release earnings on 3/30/2021. During their last earnings release the company posted EPS of $-1.87. -We do not have a set dividend date for Qualigen Therapeutics Inc at this time. Click Here to get the full Stock Score Report on Qualigen Therapeutics Inc (QLGN) Stock.
